Skip to main content
Home
FDA
  • START A TRIAL
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Webinars
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Not Yet A Subscriber?
Click here to register for a free trial

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • May 17, 2023
    Court Grants Summary Judgment to Device Company Accused of Wrongful Discharge of Sales Rep Over Off-label Marketing
  • May 2, 2023
    OPDP Researchers Move Ahead With Three Studies
  • Apr 25, 2023
    OPDP Researchers Plan Survey on How Consumers Interpret Specific Quantitative Claims
  • Apr 20, 2023
    Court: State Law Claims Involving Class II Device Cleared via De Novo Process Not Expressly Preempted
  • Apr 15, 2023
    FTC Sends Out Nearly 700 Notices of Penalty Offenses on Substantiating Claims
  • Apr 13, 2023
    District Court Dismisses Case Over Abreva Advertising Claims
  • Apr 5, 2023
    FDA Readies Final Guidance on Quantitative Efficacy and Risk Info in DTC Ads
  • Mar 28, 2023
    District Court Dismisses RICO Case Involving Patient Assistance Program
  • Mar 17, 2023
    ABPI Suspends Novo Nordisk Over Sponsored Course Promoted on LinkedIn
  • Mar 16, 2023
    Interviews with Health Care Influencers Find Resistance to Company Messaging
  • More

Good Clinical Practice

  • Sep 13, 2023
    What Should IRBs Consider in Reviewing Individual Expanded Access Submissions?
  • Sep 6, 2023
    Clinical Investigator Receives Warning Letter Over Alleged Failure To Follow Protocol
  • Aug 29, 2023
    HHS Issues Draft Scientific Integrity Policy
  • Aug 21, 2023
    FDA Releases Long-Awaited Final Informed Consent Guidance
  • Aug 6, 2023
    WHO Proposes Clinical Trial Best Practices
  • Jul 31, 2023
    SACHRP Makes Recommendations on Draft FDA DCT and OHRP Limited IRB Review Guidances, Adds New Members
  • Jul 26, 2023
    University Receives Determination Letter for Allegedly Not Revising Written IRB Procedures To Reflect Revised Common Rule
  • Jul 18, 2023
    FDA Provides ‘Good Cause’ Reasons for Missing PMR Deadlines
  • Jul 12, 2023
    SEC Charges Former Trial Statistician with Insider Trading
  • Jun 23, 2023
    OHRP Explains Use and Operation of Limited IRB Review
  • More

U.S. Food Labeling

  • Jan 5,2023
    FDA, FSIS Set Food Labeling Uniform Compliance Date
  • Jan 5,2023
    FDA Removes Stay on Yogurt Standard of Identity Provisions
  • Dec 30,2022
    FTC Expands Advertising Guide To Include All Health-Related Claims
  • Dec 22,2022
    Agencies Jointly Issue RFI for Input on Regulating Biotechnology
  • Dec 9,2022
    FDA Posts Clarifying Guidances on Food Allergen Labeling, Asks for Comments on 'Milk,' 'Eggs'
  • Nov 23,2022
    Cell Culture Food Gets First FDA Safety Go-Ahead
  • Nov 10,2022
    Court Enjoins Distribution of Adulterated, Misbranded Supplements
  • Oct 27,2022
    FDA Officials Explain Need for ‘Healthy’ Labeling Proposal, FOP Labeling
  • Oct 12,2022
    Poll Results Show Strong Support for MCOOL Labeling for Beef
  • Sep 29,2022
    FDA Proposes Updates to Definition, Nutrient Content Claim for ‘Healthy’
  • More

FDA Regulation & Enforcement

  • Feb 24, 2025
    FDA Pushes ‘Healthy’ Claim Final Rule Effective Date to April
  • Feb 21, 2025
    HFP Head Resigns Over ‘Indiscriminate’ Staff Layoffs
  • Feb 19, 2025
    First Circuit Sets High Bar for Establishing False Claims Violations Tied to Kickback Violations
  • Feb 12, 2025
    State Unfair Practices Claim Targeting Prescription Pet Food Is Preempted, District Court Rules
  • Feb 12, 2025
    Senators Ask FDA To Review Compounder’s Super Bowl Ad
  • Feb 7, 2025
    FDA Ponders SOI for High-Protein Yogurt
  • Feb 5, 2025
    Appeals Court Upholds Dismissal of Challenge to HHS OIG Advisory Opinion on Coalition Model PAP
  • Jan 31, 2025
    Sen. Sanders To Reintroduce Food Warning Label Legislation
  • Jan 29, 2025
    Pfizer To Pay Nearly $60 Million To Resolve Kickback Allegations Arising From Subsidiary’s Speaker Programs
  • Jan 29, 2025
    Court Dismisses False Claims Allegations Against IVD Device Maker, Citing Rule 9(b) Particularity
  • More

Medical Devices

  • Apr 10, 2024
    Court Enters Consent Decree Against Philips Respironics Following Recall of Sleep Therapy Devices
  • Apr 4, 2024
    Failure-To-Warn, Strict Liability, Negligence Claims Involving Class III PMA Device Survive Preemption
  • Mar 27, 2024
    FDA Again Proposes To Ban Electrical Stimulation Devices Intended for Behavioral Treatments
  • Mar 21, 2024
    Device Associations Cautious Following Release of EPA Final Rule on Ethylene Oxide Emissions
  • Mar 14, 2024
    Draft Guidance Outlines FDA’s Expectations for Meeting FDORA Submission Mandates for Cyber Devices
  • Mar 13, 2024
    Jury Returns Verdict Against CEO of Firm That Marketed Neurostimulation Device With Phony Component
  • Mar 6, 2024
    Challenges Posed by AI/ML-Enabled Devices May Require Congress To Give FDA New Authorities
  • Feb 29, 2024
    Citing Data Integrity Concerns, FDA Warns Device Study Sponsors About Fraudulent Lab Testing
  • Feb 21, 2024
    FDA Suggests Only Small Businesses in Bankruptcy May Qualify for Device Establishment Fee Waivers
  • Feb 21, 2024
    CDRH Reorganizes Office of Strategic Partnerships and Technology Innovation Into ‘Super Office’
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports
  • Webinars
  •  

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • Headquarters
  • 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.